Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oncology drugs
Podcast
AbbVie, ADCs and the future of cancer care
In this episode of "The Top Line," AbbVie’s Daejin Abidoye, M.D., joins us to discuss the future of antibody drug conjugates.
Ayla Ellison
,
Zoey Becker
Jun 20, 2025 9:39am
Gilead's Trodelvy chalks up another phase 3 breast cancer win
May 23, 2025 10:10am
FDA advisors unanimously reject Pfizer's Talzenna expansion bid
May 22, 2025 10:20am
Drug spending surged in 2024, driven by obesity and oncology meds
May 5, 2025 11:27am
Angus on Angus: A Fierce oncology discussion
Apr 25, 2025 9:41am
Where is the industry going with its rush to radiopharma?
Jan 10, 2025 3:00am
